Leukemia Without Leukocytosis (Aleukemic Myelosis) and Without Splenomegaly

Mettier, Stacy R.

doi:10.1001/archinte.1937.00180030075008

Cited by 6 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a case series, many patients with aleukemic myelosis endorsed dyspnea, weakness, and palpitations [ 16 ]. Aleukemic leukemia cutis is a manifestation in which patients develop cutaneous manifestations of the disease, generally preceding the development of systemic leukemia [ 18 ]. In our patient’s case, he was diagnosed with APL; however, he had an absence of leukocytosis, splenomegaly, and cutaneous features.…”

Section: Discussionmentioning

confidence: 99%

Aleukemic Acute Promyelocytic Leukemia: How Concomitant HIV, Hepatitis C, and Chronic Alcohol Use Disorder May Have Hidden an Underlying Malignancy

et al. 2023

View full text Add to dashboard Cite

Patient: Male, 67-year-old Final Diagnosis: Acute promyelocytic leukemia Symptoms: Exertional dyspnea • nocturia • orthopnea • weight gain Clinical Procedure: — Specialty: General and Internal Medicine • Oncology Objective: Rare disease Background: Acute promyelocytic leukemia (APL) is a rare subtype of acute myeloid leukemia (AML) and is characterized by a genetic translocation affecting the retinoic acid receptor-alpha gene, leading to blockage in the differentiation of granulocytic cells. The accumulation of promyelocytes in bone marrow leads to cytopenias and life-threatening coagulopathies. Definitive diagnosis is made with bone marrow biopsy. Differentiation of APL from other leukemias is important to appropriately treat with all-trans retinoic acid (ATRA) and arsenic trioxide. Patients with HIV are at a higher risk to develop AML. This article identifies how multiple comorbidities and social factors can contribute to difficulties in diagnosing AML. Case Report: We present a 67-year-old man with a past medical history of hypertension and substance use disorder who presented with progressive exertional dyspnea and was found to have HIV, chronic hepatitis C, and APL with pancytopenia. His bone marrow biopsy confirmed AML. This was a case of co-existing HIV and aleukemic leukemia. Conclusions: APL can present with pancytopenia, weakness, failure to thrive, or bleeding complications, which can be similar to presentations of those diagnosed with HIV. Diagnosis of APL can be differentiated between hypergranular and hypogranular; our patient demonstrated APL with only 52% blasts, which can make for a challenging diagnosis. Given increased mortality of APL, immediate ATRA therapy is warranted. Aleukemic leukemia is a rare presentation typically accompanied by skin manifestations. Our case highlights the importance of having high clinical suspicion for malignancy in patients with comorbidities that can interfere with the classic presentation of leukemia.

show abstract

Section: Discussionmentioning

confidence: 99%